C07C 233/06
Having the nitrogen atom of at least one of the carboxamide groups
Official title: having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
C07C233/06 (Having the nitrogen atom of at least one of the carboxamide groups) appears on 79 US grants and 65 published applications in this corpus.
Search patents in C07C- Granted patents
- 79
- Published applications
- 65
- Assignees
- 62
- Inventors
- 229
- Latest grant
- 17 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 4 | 0 |
| 1998 | 4 | 0 |
| 1999 | 7 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 1 |
| 2003 | 1 | 1 |
| 2004 | 1 | 0 |
| 2005 | 2 | 1 |
| 2006 | 0 | 2 |
| 2007 | 1 | 2 |
| 2008 | 0 | 3 |
| 2009 | 0 | 4 |
| 2010 | 2 | 3 |
| 2011 | 4 | 5 |
| 2012 | 2 | 1 |
| 2013 | 4 | 4 |
| 2014 | 2 | 4 |
| 2015 | 4 | 1 |
| 2016 | 5 | 9 |
| 2017 | 2 | 1 |
| 2018 | 0 | 3 |
| 2019 | 5 | 4 |
| 2020 | 3 | 4 |
| 2021 | 1 | 2 |
| 2022 | 3 | 2 |
| 2023 | 2 | 2 |
| 2024 | 3 | 3 |
| 2025 | 1 | 1 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions for preventing and/or treating degenerative disorders of the central nervous system and/or lysosomal storage disorders17 Feb 2026US 12,552,736 B2Amicus Therapeutics, Inc.
- Modulators of liver receptor homologue 1 (LRH-1) and uses16 Sep 2025US 12,415,770 B2Emory University Office of Technology Transfer
- Lipids for use in lipid nanoparticle formulations29 Oct 2024US 12,129,223 B2Acuitas Therapeutics, Inc.
- Modulators of liver receptor homologue 1 (LRH-1) and uses20 Aug 2024US 12,065,402 B2Emory University
- Prodrugs of fencamfamine5 Mar 2024US 11,919,836 B2Praxis Bioresearch, LLC
- Modulators of liver receptor homologue 1 (lrh-1) and uses26 Feb 2026US 2026/0055046 A1Emory University
- Catalytic chemical recycling of polyamide-based plastics12 Feb 2026US 2026/0042730 A1Northwestern University
- Lipids for use in lipid nanoparticle formulations12 Jun 2025US 2025/0188020 A1Acuitas Therapeutics, Inc.
- Modulators of liver receptor homologue 1 (lrh-1) and uses7 Nov 2024US 2024/0368066 A1Emory University
- Small molecule modulators of ferroptosis26 Sep 2024US 2024/0315994 A1Arpeggio Biosciences, Inc.
Most cited
By later US patents
- Potent inducers of terminal differentiation and methods of use thereof95US 5,369,108 ASloan-Kettering Institute for Cancer Research · 1994
- Potent inducers of terminal differentiation and methods of use thereof91US 6,087,367 ASloan-Kettering Institute for Cancer Research · 2000
- Potent inducers of terminal differentiation and method of use thereof89US 5,700,811 ASloan-Kettering Institute for Cancer Research · 1997
- Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives68US 5,877,218 ATeva Pharmaceutical Industries Ltd. · 1999
- Potent inducers of terminal differentiation and methods of use thereof50US 5,932,616 ASloan-Kettering Institute for Cancer Research · 1999